Ulka Sachdev

Dr. Ulka Sachdev

University of Pittsburgh School of Medicine
orcid

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2006 in Journal of Vascular Surgery
Verified
Journal Article
Closed access
USUlka Sachdev
Ulka Sachdev
DBDonald T. Baril
Donald T. Baril
SESharif H. Ellozy
Sharif H. Ellozy
RLRobert A. Lookstein
Robert A. Lookstein
DSDaniel Silverberg
Daniel Silverberg
MMMichael L. Marin
Michael L. Marin

20 May 2010 in Mount Sinai Journal of Medicine: A Journal of Translational and Personalized Medicine
Verified
Journal Article
Closed access
PDF file
USUlka Sachdev
Ulka Sachdev

8 December 2020 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
GCGuangzhi Cong
Guangzhi Cong
XCXiangdong Cui
Xiangdong Cui
RFRicardo Jose Ferrari
Ricardo Jose Ferrari
IPIraklis Pipinos
Iraklis Pipinos
GCGeorge Casale
George Casale
USUlka Sachdev
Ulka Sachdev
Most patients with critical limb ischemia (CLI) from peripheral arterial disease (PAD) do not have antecedent intermittent claudication (IC). We hypothesized that transcriptomic analysis would identify CLI-specific pathways, particularly in regards to fibrosis. Derivation cohort data from muscle biopsies in PAD and non-PAD (controls) was obtained from the Gene Expression Omnibus (GSE120642). Transcriptomic analysis indicated CLI patients (N = 16) had a unique gene expression profile, when compared with non-PAD controls (N = 15) and IC (N = 20). Ninety-eight genes differed between controls and IC, 2489 genes differed between CLI and controls, and 2783 genes differed between CLI and IC patients. Pathway enrichment analysis showed that pathways associated with TGFβ, collagen deposition, and VEGF signaling were enriched in CLI but not IC. Receiver operating curve (ROC) analysis of nine fibrosis core gene expression revealed the areas under the ROC (AUC) were all >0.75 for CLI. Furthermore, the fibrosis area (AUC = 0.81) and % fibrosis (AUC = 0.87) in validation cohort validated the fibrosis discrimination CLI from IC and control (all n = 12). In conclusion, transcriptomic analysis identified fibrosis pathways, including those involving TGFβ, as a novel gene expression feature for CLI but not IC. Fibrosis is an important characteristic of CLI, which we confirmed histologically, and may be a target for novel therapies in PAD.

16 June 2017 in Journal of Leukocyte Biology
Verified
Journal Article
Closed access
PDF file
USUlka Sachdev
Ulka Sachdev
MLMichael Thomas Lotze
Michael Thomas Lotze
Current studies of vascular health, aging, and autophagy emphasize how the endothelium adapts to stress and contributes to disease. The endothelium is far from an inert barrier to blood-borne cells, pathogens, and chemical signals; rather, it actively translates circulating mediators into tissue responses, changing rapidly in response to physiologic stressors. Macroautophagy—the cellular ingestion of effete organelles and protein aggregates to provide anabolic substrates to fuel bioenergetics in times of stress—plays an important role in endothelial cell homeostasis, vascular remodeling, and disease. These roles include regulating vascular tone, sustaining or limiting cell survival, and contributing to the development of atherosclerosis secondary to infection, inflammation, and angiogenesis. Autophagy modulates these critical functions of the endothelium in a dynamic and perpetual response to tissue and intravascular cues.

1 January 2015 in Molecular Medicine
Verified
Journal Article
Open access
JXJia Xu
Jia Xu
KBKelly Benabou
Kelly Benabou
XCXiangdong Cui
Xiangdong Cui
MMMarissa Madia
Marissa Madia
ETEdith Tzeng
Edith Tzeng
USUlka Sachdev
Ulka Sachdev
Toll-like receptors (TLRs) play an important role in regulating muscle regeneration and angiogenesis in response to ischemia. TLR2 knockout mice exhibit pronounced skeletal muscle necrosis and abnormal vessel architecture after femoral artery ligation, suggesting that TLR2 signaling is protective during ischemia. TLR4, an important receptor in inflammatory signaling, has been shown to regulate TLR2 expression in other systems. We hypothesize that a similar relationship between TLR4 and TLR2 may exist in hindlimb ischemia in which TLR4 upregulates TLR2, a mediator of angiogenesis and perfusion recovery. We examined the expression of TLR2 in unstimulated and in TLR-agonist treated endothelial cells (ECs). TLR2 expression (low in control ECs) was upregulated by lipopolysaccharide, the danger signal high mobility group box-1, and hypoxia in a TLR4-dependent manner. Endothelial tube formation on Matrigel as well as EC permeability was assessed as in vitro measures of angiogenesis. Time-lapse imaging demonstrated that ECs lacking TLR4 formed more tubes, whereas TLR2 knockdown ECs exhibited attenuated tube formation. TLR2 also mediated EC permeability, an initial step during angiogenesis, in response to high-mobility group box-1 (HMGB1) that is released by cells during hypoxic injury. In vivo, ischemia-induced upregulation of TLR2 required intact TLR4 signaling that mediated systemic inflammation, as measured by local and systemic IL-6 levels. Similar to our in vitro findings, vascular density and limb perfusion were both enhanced in the absence of TLR4 signaling, but not if TLR2 was deleted. These findings indicate that TLR2, in the absence of TLR4, improves angiogenesis and perfusion recovery in response to ischemia.

1 May 2018 in Journal of Vascular Surgery: Venous and Lymphatic Disorders
Verified
Journal Article
Closed access
USUlka Sachdev
Ulka Sachdev
LVLena Vodovotz
Lena Vodovotz
JBJulie Bitner
Julie Bitner
DBDerek Barclay
Derek Barclay
RZRuben Zamora
Ruben Zamora
YVYoram Vodovotz
Yoram Vodovotz